Patent ID: 11858990
Assignee: INNATE PHARMA
Field: Measurement (Instruments)
Classification: CPC C  A  G | IPC A  C  G

Claim 4:
5. A method for identifying a KIR3DL2-expressing cell in a subject, the method comprising obtaining a biological sample from a subject comprising cells, bringing said cells into contact with an antibody and assessing whether the antibody binds to the cells, said antibody having (i) a heavy chain CDRs 1, 2 and 3 (HCDR1, HCDR2, HCDR3), according to the Kabat definition, of the heavy chain variable region sequence of SEQ ID NO: 13, and (ii) a light chain CDRs 1, 2 and 3 (LCDR1, LCDR2, LCDR3), according to the Kabat definition, of the light chain variable region sequence of SEQ ID NO: 14, the subject having or being suspected of having a CD4+ T cell lymphoma or an autoimmune disease.